Health care stocks didn't do much for the first half of 2016, but Jim Cramer is ready for them to go into bull mode for the rest of the year.
Many investors fled the faster growth pharmaceutical and biotech names, and the best performing health care stocks of the first half were medical device plays.
"I think these patterns will continue through the second half, with winners staying winners all the way," the "Mad Money" host said.
The health care cohort was down 0.4 percent in the first half. This was partly due to companies taking the heat for higher drug prices as highlighted by Hillary Clinton last fall. Valeant and the dissolved merger between Pfizer and Allergan also contributed.
HMOs, hospitals, laboratory service plays and medical device makers were all pockets of strength, which offset the weakness.
The top five performers in health care were Stryker, Boston Scientific, St. Jude, Edwards Lifesciences and C R Bard. The losers in the group were Endo International, Perrigo, Alexion, Regeneron and Vertex Pharma.
So, while there were both big winners and big losers of the group this year, Cramer found health care winners to be clear cut. He expects the strength to continue for the rest of the year.